(27 June 2022) CSAM Health Group AS (the «Company») has decided to initiate a buyback of up to 333,333 of its own shares in accordance with the authorisation granted to the board of directors by the Company’s general meeting held on 19 May 2022.
The share buyback programme will be for a maximum consideration of NOK 20 million, and for a maximum of 333,333 shares. The repurchases will be conducted in the period from 27 June 2022 until and including 31 December 2022, or until the maximum number of shares have been repurchased. Buyback transactions will be executed according to the market price on the Oslo Stock Exchange, and the maximum price to be paid per share under the programme is NOK 60.
Shares acquired as part of the buyback programme are primarily intended to be used as consideration in future acquisitions by the company. Any shares purchased will be held in treasury until used for the above purposes.
The number of shares acquired per day shall not exceed 5,526, representing 20% of the average daily trading volume for May 2022. This limit is lower than the maximum set out in the Market Abuse Regulation (MAR) requirements as described in Article 3 of the EU Commission delegated regulation 2016/1052, and as implemented in Norway under the Securities Trading Act.
The programme will be managed by Carnegie AS, which will make its trading decisions in relation to the acquisition of shares independently of, and uninfluenced by, the Company.
Information on trading will be announced via the Oslo Børs service NewsPoint.
For further information, please contact:
Chief Financial Officer
+47 91 55 45 32
CSAM Health Group is the leading provider of specialised software for healthcare in the Nordics. From this solid foundation the company has grown to serve more than 500 customers in 25 countries. Our highly specialised software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. CSAM’s headquarters are in Oslo, Norway. CSAM is represented in ten countries across Europe, Asia, Oceania and North America, including a wholly-owned software engineering subsidiary in the Philippines.